Holdings of the Fund as of 7/6/2020
Total Number of Holdings (excluding cash): 30
| Ultragenyx Pharmaceutical Inc. |
RARE |
Health Care |
1,112,235 |
$96,486,386.25 |
4.37% |
| BioMarin Pharmaceutical Inc. |
BMRN |
Health Care |
730,957 |
$93,350,518.47 |
4.22% |
| Sarepta Therapeutics, Inc. |
SRPT |
Health Care |
549,271 |
$89,800,315.79 |
4.06% |
| Neurocrine Biosciences, Inc. |
NBIX |
Health Care |
658,282 |
$84,036,280.12 |
3.80% |
| Bio-Techne Corporation |
TECH |
Health Care |
304,389 |
$82,139,371.65 |
3.72% |
| Charles River Laboratories International, Inc. |
CRL |
Health Care |
449,213 |
$81,666,923.40 |
3.69% |
| Seattle Genetics, Inc. |
SGEN |
Health Care |
476,069 |
$81,145,961.05 |
3.67% |
| Nektar Therapeutics |
NKTR |
Health Care |
3,351,978 |
$80,380,432.44 |
3.64% |
| Agios Pharmaceuticals, Inc. |
AGIO |
Health Care |
1,435,057 |
$78,712,876.45 |
3.56% |
| Alkermes Plc |
ALKS |
Health Care |
3,981,295 |
$78,152,820.85 |
3.54% |
| Illumina, Inc. |
ILMN |
Health Care |
205,911 |
$78,120,574.29 |
3.53% |
| Exact Sciences Corporation |
EXAS |
Health Care |
872,619 |
$77,671,817.19 |
3.51% |
| Exelixis, Inc. |
EXEL |
Health Care |
3,350,398 |
$77,528,209.72 |
3.51% |
| United Therapeutics Corporation |
UTHR |
Health Care |
622,472 |
$74,099,066.88 |
3.35% |
| Ionis Pharmaceuticals, Inc. |
IONS |
Health Care |
1,182,802 |
$71,884,791.76 |
3.25% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
Health Care |
470,278 |
$71,684,475.54 |
3.24% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
Health Care |
114,279 |
$71,681,502.75 |
3.24% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
Health Care |
1,331,838 |
$71,506,382.22 |
3.23% |
| Alexion Pharmaceuticals, Inc. |
ALXN |
Health Care |
629,319 |
$71,471,758.83 |
3.23% |
| IQVIA Holdings Inc. |
IQV |
Health Care |
495,028 |
$71,105,821.92 |
3.22% |
| Amgen Inc. |
AMGN |
Health Care |
277,006 |
$70,982,787.50 |
3.21% |
| FibroGen, Inc. |
FGEN |
Health Care |
1,640,968 |
$70,774,949.84 |
3.20% |
| Incyte Corporation |
INCY |
Health Care |
651,437 |
$70,218,394.23 |
3.18% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
Health Care |
240,667 |
$70,108,703.77 |
3.17% |
| QIAGEN N.V. |
QGEN |
Health Care |
1,605,684 |
$69,461,889.84 |
3.14% |
| bluebird bio, Inc. |
BLUE |
Health Care |
1,169,110 |
$67,901,908.80 |
3.07% |
| Gilead Sciences, Inc. |
GILD |
Health Care |
775,720 |
$59,544,267.20 |
2.69% |
| Grifols, S.A. (ADR) |
GRFS |
Health Care |
3,113,414 |
$59,310,536.70 |
2.68% |
| Biogen Inc. |
BIIB |
Health Care |
190,113 |
$51,292,487.40 |
2.32% |
| Intercept Pharmaceuticals, Inc. |
ICPT |
Health Care |
801,526 |
$36,950,348.60 |
1.67% |
| US Dollar |
$USD |
Other |
1,252,761 |
$1,252,760.82 |
0.06% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|